Streetbeat News

Earnings

THS

TreeHouse Foods, Inc. (NYSE:THS) reported Q2 sales growth of 4.1% YoY to $843.60 million, beating the consensus of $829.85 million. Adjusted EPS improved to 42 cents, beating the consensus estimate of 40 cents. The company also reported a gross margin expansion and a decrease in total operating expenses. The company expects Q3 revenue of $950 million-$970 million, representing approximately 10% YoY growth at the midpoint. FY23 net sales growth is now expected to be 7.5%-9.5% YoY.

Portfolio Pulse from Nabaparna Bhattacharya

August 07, 2023 | 1:22 pm

CCF

KKR

KKR & Co Inc reported Q2 2023 revenues of $3.63 billion, significantly higher than $323.4 million a year ago. The company's after-tax adjusted distributable EPS was $0.73, down 23% Y/Y, but beat the consensus of $0.71. Asset management segment revenues and net investment income in the insurance segment also beat consensus. KKR declared a dividend per share of $0.165. In July, KKR acquired Chase Corporation for approximately $1.3 billion.

Portfolio Pulse from Lekha Gupta

August 07, 2023 | 1:18 pm

JELD

JELD-WEN Holding, Inc. (NYSE:JELD) is expected to report lower Q2 earnings at 33 cents per share, down from 57 cents per share a year ago. The company's revenue might be around $1.1 billion, compared to $1.33 billion last year. JELD-WEN shares rose 1.6% to close at $17.99 on Friday. Several analysts have maintained their ratings and raised their price targets for JELD-WEN.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 1:16 pm

GTBP

GT Biopharma reported Q2 losses of $(0.05) per share, beating the analyst consensus estimate of $(0.10) by 50%. This is a 50% increase over losses from the same period last year.

Portfolio Pulse from Happy Mohamed

August 07, 2023 | 1:16 pm

PLX

Protalix BioTherapeutics reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:13 pm

TRHC

Tabula Rasa HealthCare's shares are trading higher following the company's Q2 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:10 pm

SOHU

Sohu.com Limited reported a 22% YoY decline in Q2 2023 revenue to $152.1 million, missing the consensus of $153.7 million. Brand advertising revenues and online game revenues also declined. However, the non-GAAP gross margin expanded by 300 bps YoY to 76%. The company held $1.4 billion in cash and equivalents. Sohu CEO Charles Zhang emphasized the company's 'Twin Engine' strategy and its potential to gain more advertising dollars.

Portfolio Pulse from Anusuya Lahiri

August 07, 2023 | 1:06 pm

CCO

DMS

GOGO

LIZI

MANU

MAX

MOXC

MSGM

NCTY

TKAT

TKC

Several communication services stocks experienced significant movement in Monday's pre-market session. Moxian, Turkcell Iletisim, Manchester United, Lizhi, The9, and MediaAlpha saw gains, while Takung Art, Clear Channel Outdoor, Gogo, Motorsport Games, and Digital Media Solutions experienced losses. Q2 earnings were recently released for MediaAlpha, Clear Channel Outdoor, and Gogo.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 1:06 pm

BNED

FRGI

GENI

In Monday's pre-market session, 12 consumer discretionary stocks showed significant movement. Genius Sports (GENI), AYRO, Genius Gr (GNS), EBET, JOANN (JOAN), and Fiesta Restaurant Gr (FRGI) were gainers, with GENI and FRGI releasing Q2 earnings. Losers included Barnes & Noble Education (BNED), Polished.com (POL), XWELL (XWEL), Tupperware Brands (TUP), Unique Fabricating (UFAB), and Yoshiharu Global (YOSH), with BNED releasing its Q4 earnings report.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 1:06 pm

NKTR

SAGE

VTGN

Several healthcare stocks experienced significant movement in Monday's pre-market session. Vistagen Therapeutics, Nektar Therapeutics, Tabula Rasa HealthCare, T2 Biosystems, Gracell Biotechnologies, and Protalix BioTherapeutics saw increases, while Sage Therapeutics, Tivic Health Systems, Aceragen, Quantum-Si, Apellis Pharmaceuticals, and HUTCHMED (China) saw declines. Q2 earnings were released for several of these companies.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 1:05 pm